Green rows = improving QoQ · red rows = declining. Figures indicative, drawn from reported results & guidance.
Latest earnings / delivery
Solid quarter
ROE held around 13.3% with strong capital ratios and low credit losses; net interest income easing modestly from the rate peak but offset by fees and disciplined costs.
Capital return
A well-covered ~8% dividend plus buybacks; the annual dividend (ex-date ~March) is estimated at SEK 20.45 or higher.
Catalysts vs Risks
▲ Catalysts
Continued high capital returnMEDIUM
Nordic economic resilienceMEDIUM
Cost discipline supporting ROEMEDIUM
▼ Risks
Legacy AML / regulatory overhangHIGH IMPACT
Falling rates compress NIIHIGH IMPACT
Swedish housing / mortgage exposureMEDIUM
Bottom line
Buy · Buy/Sell 59/100 · PT +3%
SELL / AVOIDHOLDATTRACTIVE BUY
The lowest-risk holding in the book: a well-capitalised Nordic bank with 13.3% ROE and a covered ~8% dividend. At 373.60 kr it sits just below a fresh high, so upside is limited and it earns its Buy on income and quality rather than a re-rating. The lingering AML/regulatory history is the main tail risk. It anchors the portfolio against the REIT, rate and crypto clusters.
Generated August 24, 2026. Prices reflect the last completed session (August 21, 2026), sourced via AlphaVantage & web research; some quotes carry data-provider lag — verify live prices before acting. 12-month charts are indicative. Risk score = Valuation 35% · Financial Health 35% · Growth 30% (0 = low risk, 100 = high risk). Buy/Sell weighs current price level against fundamentals (0 = avoid, 100 = attractive). For informational purposes only — not investment advice.